Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.
about
Pathology and biology of radiation-induced cardiac diseaseModulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospectsMitochondrial dysfunction in obesity: potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndromeBeneficial role of bitter melon supplementation in obesity and related complications in metabolic syndromeMetabolic syndrome, inflammation and atherosclerosisAtheroprotective effect of oleoylethanolamide (OEA) targeting oxidized LDLAre thiazolidinediones good or bad for the heart?Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic DrugsCCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice.Correlation between PPARγ protein expression level in granulosa cells and pregnancy rate in IVF programEffects of the interaction of diabetes and iron supplementation on hepatic and pancreatic tissues, oxidative stress markers, and liver peroxisome proliferator-activated receptor-α expression.Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.Cardiovascular events associated with second-line anti-diabetes treatments: analysis of real-world Korean data.Enterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells.Regulation of Wnt/beta-catenin pathway by cPLA2alpha and PPARdeltaMetabolomics as an extension of proteomic analysis: study of acute kidney injury.Cardiometabolic interventions - focus on transcriptional regulators.Genetics of the cardiometabolic syndrome: new insights and therapeutic implications.Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.Blocking the peroxisome proliferator-activated receptor (PPAR): an overview.Effect of oxime ether incorporation in acyl indole derivatives on PPAR subtype selectivity.The natural carotenoid astaxanthin, a PPAR-α agonist and PPAR-γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes.IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues.Peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and risk of osteopenia in β-thalassemia major patients.Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice.Isoliquiritigenin suppresses tumor necrosis factor-α-induced inflammation via peroxisome proliferator-activated receptor-γ in intestinal epithelial cells.
P2860
Q26740040-F5A0A2B5-1940-4354-8704-7FF2A46A5E78Q26829098-A1AF0FE7-F497-43F1-AF3C-0E846569C49EQ27009336-3AFC775D-FEAE-4BA3-B535-200408003EFCQ28081950-A00A558C-BACF-470F-A8F1-985648AE0A8CQ28219348-9BB15B41-FA4A-42A7-87BA-675A11B32D33Q28538861-BB76DCBA-B514-45D1-B741-AAE355F19BC4Q30435005-5F7DE259-59CA-49B1-B246-EF2AA363C6F2Q33809886-2B92FACF-723A-49E3-8314-0140D75D9230Q33943164-F2D49EDB-0978-4C3D-AF1B-B2B11A3C2B48Q34176529-D635B709-F734-43DC-96CF-61992C08C753Q35209655-3B355D75-123A-4F0A-842B-FB36FA564525Q35625960-E437308D-8D4C-4D3D-82F7-AC87A136E66BQ36376273-17F191C9-24B1-4B77-B2A5-B564EF992CC8Q36882991-1A26E2D7-2B77-4ABE-AEA7-23F2385FC116Q36995029-5323C891-96CF-4BAC-8C0B-3EF981AE5527Q37025529-AB6B4BC0-432D-41EE-A96A-7CB404F9F4CDQ37161933-F3E1F546-E41A-4D38-BBAB-99AE7413018EQ37362678-22978AC9-34E4-45DA-8918-DFB65972A05EQ37393336-ED692E22-A0C1-403E-8ACF-80EAE48A76D1Q38128537-276E3E8E-B8E5-4F5B-8BE5-EDE8C0434BF8Q38320967-0C93A71A-0199-4466-BA40-077AA35F80EDQ38324364-A5CBA41B-3A2A-483C-AB89-56E2ADEE1861Q40108534-C92A7C97-D735-485C-BF6D-BAFDC1AF0485Q46431587-443E4940-D1A1-4232-AEDA-F14F3E81A874Q46722608-3B5975E3-8D32-4B4B-B17A-C786423AA5A0Q51563136-89687A26-F4CA-4E46-9A58-6752EA9F20DF
P2860
Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Role of the PPAR family of nuc ...... is: new approaches to therapy.
@ast
Role of the PPAR family of nuc ...... is: new approaches to therapy.
@en
type
label
Role of the PPAR family of nuc ...... is: new approaches to therapy.
@ast
Role of the PPAR family of nuc ...... is: new approaches to therapy.
@en
prefLabel
Role of the PPAR family of nuc ...... is: new approaches to therapy.
@ast
Role of the PPAR family of nuc ...... is: new approaches to therapy.
@en
P1476
Role of the PPAR family of nuc ...... is: new approaches to therapy.
@en
P2093
Giulia Chinetti-Gbaguidi
P304
P356
10.1016/J.COPH.2004.11.004
P577
2005-04-01T00:00:00Z